IGEA S.p.A.

📍 Carpi, Italy🗓 Founded 1980👥 225 employees💰 Last funded Jan 2008
Medical Equipment Manufacturing🌐 igeamedical.com
Website LinkedIn
IGEA studies the clinical application of physical stimuli to biological systems. Our mission is to improve patients’ quality of life by developing and producing innovative, effective and safe therapeutic systems for clinical practice. IGEA develops biophysical treatments in two main areas: - Orthopedics: to improve bone healing and joint preservation. - Oncology: to treat cancer. IGEA is the world leading company for Electrochemotherapy, a minimally invasive treatment combining a low dose of a chemotherapy drug and electrical pulses (electroporation) applied directly to the cancer cells using specific multiple or individual electrodes. Cliniporator® and Cliniporator® VITAE are the most advanced electroporation technologies for the treatment of tumor nodules located to the skin, subcutaneous tissue, parenchyma and bone.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
1980
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Italy
1
Frequently asked questions
Who invested in IGEA S.p.A.?
IGEA S.p.A. has 1 investors on record on gritt.io.
When did IGEA S.p.A. last raise funding?
The most recent investment in IGEA S.p.A. recorded on gritt.io was in January 2008.
When was IGEA S.p.A. founded?
IGEA S.p.A. was founded in 1980.
What industry is IGEA S.p.A. in?
IGEA S.p.A. operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is IGEA S.p.A. based?
IGEA S.p.A. is headquartered in Carpi, Italy.